Related Experiment Video
Updated: Jan 5, 2026
06:15
Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
Published on: August 16, 2024
744
Amiodarone in the aged
Meera Srinivasan1,2,3, Laura Ahmad1,2,3, Ravinay Bhindi1,2,3
1Royal North Shore Hospital.
Australian Prescriber
|October 22, 2019
Summary
Amiodarone effectively treats arrhythmias but carries risks, especially for elderly patients. Careful patient selection, monitoring, and consideration of drug interactions are crucial to mitigate adverse effects.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Amiodarone is a potent antiarrhythmic medication.
- Its use is associated with significant adverse effects, particularly in elderly populations.
Purpose of the Study:
- To highlight the risks and considerations for using amiodarone.
- To provide guidance on appropriate patient selection and monitoring.
Main Methods:
- Review of amiodarone's efficacy and adverse event profile.
- Clinical guidelines and expert recommendations for amiodarone use.
Main Results:
- Amiodarone is highly effective for arrhythmias but not recommended solely for rate control.
- Contraindications include significant conduction disease, liver/pulmonary issues, and hyperthyroidism.
- Potential drug interactions and prolonged toxicity post-discontinuation require attention.
Conclusions:
- Amiodarone necessitates careful consideration, especially in older patients.
- Consultation with a cardiologist is advised before initiating amiodarone.
- Vigilant clinical and biochemical monitoring is essential for early detection of complications.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
168
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
168
01:15Drug Dosing: Geriatric Patients
193
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
193
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
171
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
171
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
195
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
195
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.7K